Literature DB >> 10843739

Expression of IL-8 gene in human monocytes and lymphocytes: differential regulation by TNF and IL-1.

Y V Chaly1, R S Selvan, K V Fegeding, T S Kolesnikova, N N Voitenok.   

Abstract

TNF-alpha and IL-1 were reported to be the most powerful inducers of IL-8 in a multitude of cells, including leukocytes. In this study, we investigated TNF-alpha- and IL-1-mediated regulation of IL-8 gene expression in non-fractionated PBMC, and purified monocyte (MO) and lymphocyte (LY) fractions. Our analysis revealed that purified human MO did not respond to exogenous TNF-alpha with the induction of IL-8 mRNA or protein, nor require endogenous TNF-alpha for IL-8 expression. In contrast, in the presence of exogenous IL-1alpha and IL-1beta a substantial enhancement of IL-8 mRNA and protein expression in MO was observed. Nevertheless, antibodies to IL-1alpha and IL-1beta were unable to downregulate the expression of IL-8 in resting adherent or Staphylococcus aureus Cowan 1 (SAC)-stimulated MO. In contrast with MO, purified LY and non-fractionated PBMC expressed IL-8 in response to exogenous TNF-alpha, similar to exogenous IL-1alpha and IL-1beta. As was seen with MO, antibodies to TNF-alpha, IL-1alpha and IL-1beta did not inhibit the expression of IL-8 in purified LY and non-fractionated PBMC stimulated with SAC and LPS. Taken together, our data demonstrate major differences in responsiveness of MO and LY to exogenous TNF-alpha and IL-1, and suggest relative autonomy of IL-8 gene expression in these cells that does not require accessory cytokines but can be induced directly by exogenous stimuli. Copyright 2000 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10843739     DOI: 10.1006/cyto.1999.0664

Source DB:  PubMed          Journal:  Cytokine        ISSN: 1043-4666            Impact factor:   3.861


  6 in total

1.  Increased expression of TSH receptor by fibrocytes in thyroid-associated ophthalmopathy leads to chemokine production.

Authors:  Erin F Gillespie; Konstantinos I Papageorgiou; Roshini Fernando; Nupur Raychaudhuri; Kimberly P Cockerham; Laya K Charara; Allan C P Goncalves; Shuang-Xia Zhao; Anna Ginter; Ying Lu; Terry J Smith; Raymond S Douglas
Journal:  J Clin Endocrinol Metab       Date:  2012-03-07       Impact factor: 5.958

2.  Down-regulation of CXCR1 and CXCR2 expression on human neutrophils upon activation of whole blood by S. aureus is mediated by TNF-alpha.

Authors:  I Tikhonov; T Doroshenko; Y Chaly; V Smolnikova; C D Pauza; N Voitenok
Journal:  Clin Exp Immunol       Date:  2001-09       Impact factor: 4.330

3.  Phenotypes of STAT3 gain-of-function variant related to disruptive regulation of CXCL8/STAT3, KIT/STAT3, and IL-2/CD25/Treg axes.

Authors:  Lia Furlaneto Marega; Janine Schincariol Sabino; Marcus Vinicius Pedroni; Marcelo Teocchi; Carolina Lanaro; Dulcinéia Martins de Albuquerque; Irene Pereira Dos Santos; Fernando Ferreira Costa; Maria Marluce Dos Santos Vilela
Journal:  Immunol Res       Date:  2021-08-14       Impact factor: 2.829

4.  Altered Cytokine Expression and Barrier Properties after In Vitro Infection of Porcine Epithelial Cells with Enterotoxigenic Escherichia coli and Probiotic Enterococcus faecium.

Authors:  Martina Kern; Dorothee Günzel; Jörg R Aschenbach; Karsten Tedin; Angelika Bondzio; Ulrike Lodemann
Journal:  Mediators Inflamm       Date:  2017-05-14       Impact factor: 4.711

5.  Persistently elevated level of IL-8 in Chlamydia trachomatis infected HeLa 229 cells is dependent on intracellular available iron.

Authors:  Harsh Vardhan; Raini Dutta; Vikas Vats; Rishein Gupta; Rajneesh Jha; Hem Chandra Jha; Pragya Srivastava; Apurb Rashmi Bhengraj; Aruna Singh Mittal
Journal:  Mediators Inflamm       Date:  2009-05-26       Impact factor: 4.711

6.  CCL2 responses to Mycobacterium tuberculosis are associated with disease severity in tuberculosis.

Authors:  Zahra Hasan; Jacqueline M Cliff; Hazel M Dockrell; Bushra Jamil; Muhammad Irfan; Mussarat Ashraf; Rabia Hussain
Journal:  PLoS One       Date:  2009-12-29       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.